Companies: 10,795·Total market cap: $144.5T

Cardiol Therapeutics Inc.

Cardiol Therapeutics Inc.

CRDLNASDAQHealthcare● Active

$1.08

$-0.03(-2.70%)

Market Cap$120821760

P/E Ratio—

52W High$1.71

52W Low$0.88

Avg Volume691K

Open$1.13

Beta0.80

股票排行：Drug Manufacturers - Specialty & Generic·Healthcare·查看全部市值排行 →

Cardiol Therapeutics Inc.（CRDL）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · CRDL · 截至 Jun 9, 2026

关键指标

EPS (TTM)$-0.39Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)0.00Full revenue history

Dividend Yield不分红Dividend history

Shares Outstanding87.0MShares outstanding history

Next EarningsAug 13, 2026Est.Earnings history

探索 Cardiol Therapeutics Inc. 数据

分析师预测$8 · Buy

股息不分红

盈利EPS $-0.39+23.53%

财务快照

FY 2025Revenue$0.00

202320242025

FY 2025Net Income-$33.8M▲ +7.79% YoY

202320242025

FY 2025EPS$-0.39▲ +23.53% YoY

202320242025

TTM:Revenue: $0.00Net Income: -$36.4MEPS: $-0.39View income statement →

分析师评级与目标价

Buy2 位分析师

Strong Buy

0

Buy

2

Hold

0

Sell

0

Strong Sell

0

12-Month Price Target

$8.00Low

$1.08Current

$8.00Avg Target上涨空间 640.74%

$8.00High

合计: 2 · 买入占比: 100.0%

根据过去 3 个月内 2 位华尔街分析师，CRDL 共识评级为 Buy，12 个月平均目标价 $8.00 （较现价 $1.08 上涨空间 640.74%）。

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

Cardiol Therapeutics Inc.

$1.08-2.70%$120.8M #2

Assertio Holdings, Inc.

$23.43-0.04%$151.4M #3

Connect Biopharma Holdings Limited

$2.20+1.38%$138.5M #4

Hyperfine, Inc.

$1.41+2.17%$118.7M #5

$1.71-7.07%$123.5M #6

$5.63-0.35%$63.5M

股票表现

1D-2.70%

1W-2.70%

1M-18.18%

3M+10.27%

YTD+13.23%

1Y-25.00%

5Y-59.54%

关于 Cardiol Therapeutics Inc.

CEODavid G. Elsley

IPO DateJan 15, 2019

Employees18

CountryCA

Websitecardiolrx.com

Cardiol Therapeutics Inc. is a clinical-stage life sciences firm dedicated to discovering and advancing anti-fibrotic and anti-inflammatory therapies for cardiovascular disease (CVD). Its leading cand…

Drug Manufacturers - Specialty & Generic HealthcareNASDAQCA

关于股票概览与关键数据

Cardiol Therapeutics Inc.（CRDL）是 Drug Manufacturers - Specialty & Generic 行业的 Healthcare 类公司，于 Jan 15, 2019 在 NASDAQ 上市。截至最近交易日，CRDL 股价为 $1.08，市值约为 $120.8M。过去12个月累计回报 -25.00%，年初至今回报 +13.23%。

根据 2 位华尔街分析师，Cardiol Therapeutics Inc. 股票共识评级为Buy，12个月平均目标价为 $8.00。2025 财年 Cardiol Therapeutics Inc. 营收 —，净利润 -$33.8M。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。

常见问题

截至最近一个交易日，Cardiol Therapeutics Inc.（CRDL）股价为 $1.08，在 NASDAQ 上市，52周区间为 $0.88 – $1.71。

CRDL 最新股价CRDL quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 9, 2026本内容不构成投资建议